plaque psoriasis Archives - Express Pharma

Biocon Biologics receives FDA approval for biosimilar YESINTEK

Biocon Biologics gets US market entry date for Bmab 1200, a proposed biosimilar to Stelara

Janssen’s JNJ-2113 holds potential to become leading treatment for psoriasis: GlobalData

EU approval boosts Bimzelx’s profile as innovative interleukin-17 inhibitor therapy: GlobalData

Novartis secures approval in China for Cosentyx

Unichem Laboratories gets USFDA approval for Apremilast Tablets

Sun Pharma starts Phase II trial of SCD-044 for moderate to severe plaque psoriasis

Sun Pharma declares five-year positive results for ILUMYA (tildrakizumab-asmn)

Sun Pharma launches ILUMYA (tildrakizumab) in Japan

Sun Pharma receives Japan MHLW approval of ILUMYATM for the treatment of Plaque Psoriasis